Literature DB >> 31609689

Behavioral Activation for Promoting Well-Being in Mild Dementia: Feasibility and Outcomes of a Pilot Randomized Controlled Trial.

Vasiliki Orgeta1, Remco Tuijt1, Phuong Leung1, Elisabet Sole Verdaguer1, Rebecca L Gould1, Rebecca Jones1, Gill Livingston1.   

Abstract

Engaging in meaningful and enjoyable activities is an important contributor to well-being and maintaining good quality of life. There is a paucity of randomized controlled trials of interventions supporting people with mild dementia to engage in meaningful and purposeful activity. The aim of this study was to assess whether Behavioral Activation (BA) is an acceptable psychological intervention for people with mild dementia and whether a large-scale trial is feasible. Participants were randomly assigned to BA (n = 42) or treatment as usual (TAU) (n = 21). BA aimed at increasing engagement in enjoyable and meaningful activity, and preventing low mood. Follow-up was at 3 and 6 months. Assessors were blind to treatment allocation (trial registration number: ISRCTN75503960). Retention rate was above 80% at both assessment time points. Treatment acceptability and credibility were high. Depressive symptoms remained unchanged in both groups. There was evidence of improvement associated with BA for every day function (-3.92, 95% Confidence Interval (CI) -6.87 to -0.97), and engagement in meaningful and enjoyable activity (5.08, 95% CI 0.99 to 9.16) post-treatment (3 months) in comparison to TAU. Both carer-rated patient health-related quality of life (0.16, 95% CI 0.04 to 0.28) and physical health (11.31, 95% CI 2.03 to 20.59) showed evidence of improvement at 3 months. Improvements in meaningful and enjoyable activity were maintained at 6 months.BA for people with mild dementia is feasible and acceptable and may be associated with clinically significant changes in function and quality of life. A full scale randomized controlled trial of clinical effectiveness is now needed.

Entities:  

Keywords:  Acceptability; activity scheduling; behavioral activation; behavioral therapy; dementia; feasibility; low mood; pleasant events; randomized controlled trial

Year:  2019        PMID: 31609689     DOI: 10.3233/JAD-190696

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Feasibility and Acceptability of a Remotely Delivered Weighted Blanket Intervention for People Living With Dementia and Their Family Caregivers.

Authors:  Melissa L Harris; Marita G Titler
Journal:  J Appl Gerontol       Date:  2022-06-24

Review 2.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Phuong Leung; Rafael Del-Pino-Casado; Afifa Qazi; Martin Orrell; Aimee E Spector; Abigail M Methley
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

3.  An Individual Cognitive Stimulation Therapy App for People with Dementia and Carers: Results from a Feasibility Randomized Controlled Trial (RCT).

Authors:  Harleen Kaur Rai; Justine Schneider; Martin Orrell
Journal:  Clin Interv Aging       Date:  2021-12-22       Impact factor: 4.458

4.  Clinical and cost-effectiveness of a New psychosocial intervention to support Independence in Dementia (NIDUS-family) for family carers and people living with dementia in their own homes: a randomised controlled trial.

Authors:  Alexandra Burton; Penny Rapaport; Marina Palomo; Kathryn Lord; Jessica Budgett; Julie Barber; Rachael Hunter; Laurie Butler; Jessica Vickerstaff; Kenneth Rockwood; Margaret Ogden; Debs Smith; Iain Lang; Gill Livingston; Briony Dow; Helen Kales; Jill Manthorpe; Kate Walters; Juanita Hoe; Vasiliki Orgeta; Quincy Samus; Claudia Cooper
Journal:  Trials       Date:  2021-12-02       Impact factor: 2.279

Review 5.  Development of a Psychological Intervention to Promote Meaningful Activity in People Living With Mild Dementia: An Intervention Mapping Approach.

Authors:  Vasiliki Orgeta; Eleni Palpatzis; Yi Na See; Remco Tuijt; Elisabet Sole Verdaguer; Phuong Leung
Journal:  Gerontologist       Date:  2022-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.